Ruth Rodriguez Researcher at Bellvitge Biomedical Research Institute (IDIBELL), Gynecologic Cancer Group, Oncobell Program. University of Barcelona Loss-of-function screenings based in the interference of RNA have been successfully used in the last decade to identify new therapeutic targets. The use of shRNA pooled libraries allowed to individually investigate the phenotype associated to the individual silencing[...]